The clinical relevance of new insights in iron transport and metabolism - PubMed (original) (raw)
Affiliations
- PMID: 14965486
Review
The clinical relevance of new insights in iron transport and metabolism
Pierre Brissot et al. Curr Hematol Rep. 2004 Mar.
Abstract
There have been major basic advances in the field of iron metabolism in recent years. These advances include the discoveries of the HFE-1 gene, a series of transmembrane iron transporters or cotransporters (eg, divalent metal transporter-1, duodenal cytochrome b, ferroportin-1, hephaestin, and transferrin receptor-2), and two key regulatory proteins named hepcidin and hemojuvelin. Several mutations of these various proteins have been linked to human diseases. These discoveries have led to major improvements in our understanding of iron physiology and have also profoundly modified and extended the pathologic iron field. Clinical applications have rapidly emerged with the appearance of new iron overload syndromes and the practical input of new genetic tools enabling the noninvasive diagnosis of HFE-1 hemochromatosis. These basic advances are paving the road for innovative therapeutic strategies not only in iron overload syndromes but also in the wide area of chronic disease-related anemia.
Similar articles
- Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin.
Herrmann T, Muckenthaler M, van der Hoeven F, Brennan K, Gehrke SG, Hubert N, Sergi C, Gröne HJ, Kaiser I, Gosch I, Volkmann M, Riedel HD, Hentze MW, Stewart AF, Stremmel W. Herrmann T, et al. J Mol Med (Berl). 2004 Jan;82(1):39-48. doi: 10.1007/s00109-003-0508-x. Epub 2003 Nov 15. J Mol Med (Berl). 2004. PMID: 14618243 - Regulatory networks for the control of body iron homeostasis and their dysregulation in HFE mediated hemochromatosis.
Ludwiczek S, Theurl I, Bahram S, Schümann K, Weiss G. Ludwiczek S, et al. J Cell Physiol. 2005 Aug;204(2):489-99. doi: 10.1002/jcp.20315. J Cell Physiol. 2005. PMID: 15744772 - [Non-HFE-related hereditary iron overload].
Aguilar-Martinez P. Aguilar-Martinez P. Presse Med. 2007 Sep;36(9 Pt 2):1279-91. doi: 10.1016/j.lpm.2007.01.042. Epub 2007 May 30. Presse Med. 2007. PMID: 17540536 Review. French. - Current approach to hemochromatosis.
Brissot P, Troadec MB, Bardou-Jacquet E, Le Lan C, Jouanolle AM, Deugnier Y, Loréal O. Brissot P, et al. Blood Rev. 2008 Jul;22(4):195-210. doi: 10.1016/j.blre.2008.03.001. Epub 2008 Apr 21. Blood Rev. 2008. PMID: 18430498 Review. - Non-HFE hemochromatosis.
Pietrangelo A. Pietrangelo A. Semin Liver Dis. 2005 Nov;25(4):450-60. doi: 10.1055/s-2005-923316. Semin Liver Dis. 2005. PMID: 16315138 Review.
Cited by
- Molecular diagnostic and pathogenesis of hereditary hemochromatosis.
Santos PCJL, Krieger JE, Pereira AC. Santos PCJL, et al. Int J Mol Sci. 2012;13(2):1497-1511. doi: 10.3390/ijms13021497. Epub 2012 Feb 1. Int J Mol Sci. 2012. PMID: 22408404 Free PMC article. Review. - The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance.
Aguilar-Martinez P, Bismuth M, Blanc F, Blanc P, Cunat S, Dereure O, Dujols P, Giansily-Blaizot M, Jorgensen C, Konate A, Larrey D, Le Quellec A, Mura T, Raingeard I, Ramos J, Renard E, Rousseau F, Schved JF, Picot MC. Aguilar-Martinez P, et al. Haematologica. 2010 Apr;95(4):551-6. doi: 10.3324/haematol.2009.014431. Epub 2010 Feb 9. Haematologica. 2010. PMID: 20145272 Free PMC article. - Augmented internalisation of ferroportin to late endosomes impairs iron uptake by enterocyte-like IEC-6 cells.
Oates PS, Thomas C. Oates PS, et al. Pflugers Arch. 2005 Aug;450(5):317-25. doi: 10.1007/s00424-005-1421-7. Epub 2005 Jun 17. Pflugers Arch. 2005. PMID: 16075245 - Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload.
Niederkofler V, Salie R, Arber S. Niederkofler V, et al. J Clin Invest. 2005 Aug;115(8):2180-6. doi: 10.1172/JCI25683. J Clin Invest. 2005. PMID: 16075058 Free PMC article. - Bone mineral density in men with genetic hemochromatosis and HFE gene mutation.
Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y, Chalès G. Guggenbuhl P, et al. Osteoporos Int. 2005 Dec;16(12):1809-14. doi: 10.1007/s00198-005-1934-0. Epub 2005 Jun 1. Osteoporos Int. 2005. PMID: 15928800
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical